Condition Deep-Dives 10 min read·Updated 22 July 2026 Clinician-reviewed

Sickle Cell Nephropathy

A UK Consultant Nephrologist's deep-dive on kidney disease in sickle cell disease and trait — a common but under-recognised cause of CKD in UK adults of African and Caribbean heritage, where early treatment can prevent dialysis.

  • Clinically Reviewed
  • NHS & NICE Aligned
  • UK Evidence-Based
  • Last Reviewed 22 July 2026

Professor Mohammed Mahdi Althaf

Consultant Nephrologist & Acute Physician

View Credentials

Professor Mohammed Mahdi Althaf

MD, MSc, PgDip (Clin Ed), FRCP, FHEA, FASN

Consultant Nephrologist & Acute Physician · GMC 7216325

View profile →

Direct answer

Sickle cell disease causes a predictable progression — childhood hyperfiltration, adolescent microalbuminuria, adult FSGS and CKD. Screen with annual ACR and cystatin C eGFR. Treat early with ACE/ARB, hydroxycarbamide and now SGLT2 inhibitors.

Key recommendation: Up to 30% of adults with HbSS develop CKD.

Quick answer

✓ Best choices

  • Vegetables, lower-potassium fruit and whole grains
  • Sensible portions of fish, eggs, chicken or tofu
  • Olive oil and unsalted nuts in small amounts

✓ Foods to limit

  • Added salt and ultra-processed foods
  • Phosphate additives in processed meats and ready meals
  • Sugary and energy drinks

Key takeaway

Sickle cell disease causes a predictable progression — childhood hyperfiltration, adolescent microalbuminuria, adult FSGS and CKD. Screen with annual ACR and cystatin C eGFR. Treat early with ACE/ARB, hydroxycarbamide and now SGLT2 inhibitors.

Who should be cautious

People on dialysis, post-transplant, pregnant or breastfeeding, or taking prescription medication — confirm with your renal team before changes.

Sickle Cell Nephropathy

Spectrum of kidney injury in SCD

Childhood

  • Hyperfiltration: GFR often >150 ml/min/1.73m² by age 7
  • Defective urinary concentration (isosthenuria): nocturia, enuresis, dehydration risk
  • Distal renal tubular acidosis (incomplete)
  • Hyperkalaemia tendency

Adolescence / Young Adulthood

  • Microalbuminuria (ACR 3-30 mg/mmol) appears in 20-30% by age 18
  • Progresses to overt proteinuria over years

Adulthood

  • Focal segmental glomerulosclerosis (FSGS) — the dominant glomerular lesion
  • Membranoproliferative-like patterns
  • Papillary necrosis — flank pain, haematuria, sloughed papillae in urine
  • Loss of medullary architecture on imaging
  • Progressive CKD; ~12% require dialysis or transplant by age 40 in HbSS
  • Acute kidney injury — pre-renal during crises, contrast and rhabdomyolysis-related

Rare

  • Renal medullary carcinoma — almost exclusive to sickle trait; aggressive, presents with haematuria + flank mass; refer urology urgently

How to assess kidney function

Gfr Estimation

  • Creatinine-based eGFR (CKD-EPI) systematically OVERESTIMATES true GFR in SCD
  • Reasons: low muscle mass, enhanced tubular secretion of creatinine
  • Use cystatin C-based or combined creatinine-cystatin C eGFR for any decision-making
  • Measured GFR (iohexol, EDTA) for transplant work-up or research

Albuminuria

  • Annual ACR from age 10
  • Persistent ACR ≥3 mg/mmol = treat

Blood Pressure

  • Baseline BP in SCD is typically 10-15 mmHg below the general population (low SVR, vasodilatation)
  • 'Normal-range' BP (e.g. 130/80) may represent relative hypertension and a cardiovascular and renal risk factor
  • Aim for BP <120/70 in proteinuric SCD

Imaging

  • Ultrasound annually if CKD established
  • MRI for suspected medullary carcinoma (urgent referral)

When To Biopsy

  • Nephrotic-range proteinuria of unclear cause
  • Rapidly falling eGFR
  • Atypical features (active sediment, low complement)
  • Always discuss with haematology — biopsy in SCD carries higher bleeding risk; pre-procedure exchange transfusion may be needed

Kidney Vitality is a daily multivitamin developed by a UK Consultant Nephrologist using renal nutrition principles. It contains no added potassium, magnesium, phosphorus or iron, and no herbal blends. See the formulation.

Treatment

Proteinuria / CKD

  • ACE inhibitor or ARB — first-line for any microalbuminuria, regardless of BP
  • SGLT2 inhibitor — emerging evidence supports use in proteinuric SCD CKD; monitor for euglycaemic ketoacidosis and dehydration during crises
  • Statin for cardiovascular risk
  • Salt restriction
  • Avoid NSAIDs — major precipitant of AKI in SCD
  • Avoid iodinated IV contrast unless essential; use IV hydration if unavoidable

Disease-modifying

  • Hydroxycarbamide (hydroxyurea) — proven to slow CKD progression in HbSS; check for indication in all patients
  • Crizanlizumab — reduces vaso-occlusive crises
  • Voxelotor — reduces haemolysis (regulatory status changing in 2024-25)
  • L-glutamine — reduces crises
  • Chronic exchange transfusion — selected, severe disease
  • Gene therapy (exa-cel, lovo-cel) — approved in the UK from 2024 in eligible patients

Hydration

  • Maintain euvolaemia
  • Encourage 2-3 L/day of water in stable adults (less in established CKD)
  • Beware over-diuresis: triggers crisis

Anaemia Of CKD

  • Iron studies and erythropoietin levels — but interpret with caution due to baseline haemolysis
  • ESA use must be coordinated with haematology — can worsen sickling if Hb rises too high

Dialysis

  • Both HD and PD are feasible
  • Vascular access can be challenging — preserve veins early
  • Be alert to crises in the dialysis chair

Transplant

  • Excellent outcomes in selected patients
  • Pre-transplant work-up by joint haematology-nephrology team
  • Standard immunosuppression
  • Recurrence of sickle nephropathy in the graft is recognised; hydroxycarbamide continued where possible

Special situations

Pregnancy

  • High-risk; joint maternal-medicine, haematology and nephrology care
  • Pre-conception optimisation
  • Aspirin from 12 weeks for pre-eclampsia prevention
  • Continue ACE/ARB before pregnancy but stop on confirmation
  • Watch for AKI in third trimester and post-partum

Paediatric Transition

  • Structured transition from paediatric to adult sickle service
  • Continue annual ACR and eGFR screening
  • Educate young people on NSAID avoidance and hydration

Sickle Trait

  • Reassure: low risk of CKD overall
  • Counsel on avoidance of extreme exertion in hot, hypoxic environments
  • Investigate persistent haematuria promptly — urology referral for MRI to exclude medullary carcinoma

KEY MESSAGE: sickle cell nephropathy is a preventable cause of dialysis. Routine annual screening and early ACE/ARB plus hydroxycarbamide change long-term outcomes.

FSGS — Focal Segmental Glomerulosclerosis
Related reading: FSGS — Focal Segmental Glomerulosclerosis.

Key practical tips

Designed for quick scanning — what to order, what to avoid, sensible portions, common mistakes.

  • Cook from scratch when you can
  • Read sodium labels (≤ 0.3 g per 100 g is low)
  • Take any concerns to your GP or renal team early

Clinical guidance

TL;DR summary

Sickle cell disease causes a predictable progression — childhood hyperfiltration, adolescent microalbuminuria, adult FSGS and CKD. Screen with annual ACR and cystatin C eGFR. Treat early with ACE/ARB, hydroxycarbamide and now SGLT2 inhibitors.

Key takeaways
  • Up to 30% of adults with HbSS develop CKD.
  • Standard creatinine eGFR overestimates true GFR — use cystatin C.
  • Annual ACR from childhood; treat any microalbuminuria.
  • Hydroxycarbamide is disease-modifying for the kidney too.
  • Sickle trait can cause haematuria and rare renal medullary carcinoma.
Kidney Diet & Nutrition Considerations

Diet is one of the most powerful tools you have to look after your kidneys. UK renal guidance points to a Mediterranean-style, reduced-salt pattern: plenty of vegetables, lower-potassium fruit, whole grains, sensible protein, beans and pulses in moderation, oily fish and olive oil. Personal targets — for potassium, phosphate, protein and fluid — should be set by your renal team based on your bloods.

Foods to prioritise

  • Vegetables, lower-potassium fruit and whole grains
  • Sensible portions of fish, eggs, chicken or tofu
  • Olive oil and unsalted nuts in small amounts

Foods to limit

  • Added salt and ultra-processed foods
  • Phosphate additives in processed meats and ready meals
  • Sugary and energy drinks

Potassium, phosphate and protein needs vary between individuals — please confirm personal targets with your renal team or dietitian. Browse the Kidney Diet Hub for more guides in this cluster.

Frequently asked questions

What is sickle cell nephropathy?

The spectrum of kidney disease in people with sickle cell disease (SCD), from early hyperfiltration in childhood, to microalbuminuria in adolescence, to focal segmental glomerulosclerosis (FSGS), papillary necrosis and progressive CKD in adulthood. Up to 30% of adults with HbSS develop CKD.

Does sickle cell trait affect the kidneys?

Yes — though much more mildly than HbSS. Sickle cell trait causes a defect in urinary concentrating ability (isosthenuria), microscopic and rarely macroscopic haematuria, papillary necrosis, and a higher risk of renal medullary carcinoma — a rare and aggressive kidney cancer almost exclusive to sickle trait.

How is it screened and monitored?

Annual urine albumin-to-creatinine ratio (ACR) and eGFR from childhood. Standard creatinine-based eGFR overestimates true GFR in SCD because of low muscle mass and tubular creatinine secretion — cystatin C eGFR is more reliable. Blood pressure should be monitored at every visit, with caution: baseline BP is typically low, so even 'normal' readings can be relative hypertension.

What is the treatment?

ACE inhibitor or ARB for any microalbuminuria. Hydroxycarbamide (hydroxyurea) reduces sickling and slows nephropathy. SGLT2 inhibitors are now being used in proteinuric sickle cell CKD (with monitoring). Avoid NSAIDs. Maintain hydration. Treat hypertension early. Joint haematology-nephrology follow-up.

What foods are good for kidney health?

A Mediterranean-style, mostly plant-based, reduced-salt diet is the most consistent evidence-based pattern for kidney health. Build meals around vegetables, lower-potassium fruit, whole grains, fish, eggs or tofu, beans and pulses in moderation, and olive oil.

Nutritional challenges in kidney disease

Many people living with kidney disease have to limit foods because of potassium, phosphate, diabetes, dialysis, appetite changes or simply the time it takes to cook from scratch every day. That can make it harder to keep daily nutrition balanced — particularly for vitamins and minerals that food alone may not fully cover.

Kidney Vitality is a UK-formulated daily nutritional support product designed by Consultant Nephrologist Professor Mohammed Mahdi Althaf with renal nutrition in mind from the start. It keeps doses moderate, leaves out added potassium, phosphate and magnesium, and avoids megadose vitamin A — sitting alongside a kidney-friendly diet, not replacing it.

Why Kidney Vitality fits this need

Built around UK renal guidance

Aligned with the British Society for Haematology and UK Renal Association sickle nephropathy pathway.

Designed by a UK Consultant Nephrologist

Formulated and reviewed by Professor Mohammed Mahdi Althaf (GMC 7216325).

Joint haematology-nephrology approach

Practical UK guidance reflecting modern disease-modifying therapy including hydroxycarbamide and gene therapy.

Designed by a UK Consultant Nephrologist

Ready to support your kidney health?

If you have been researching kidney health, supplements, CKD nutrition or kidney-friendly living, Kidney Vitality was developed specifically around those principles by Professor Mohammed Mahdi Althaf (GMC 7216325). Nephrologist Developed Daily Multivitamin.

  • No Added Potassium
  • No Added Magnesium
  • No Added Phosphorus
  • No Added Iron
  • One capsule daily
  • UK GMP — BRCGS, NSF GMP, Halal
Subscribe & Save — £20.39/monthCheck your current multivitamin

✓ Free UK tracked delivery  ·  ✓ Delivered every 30 days  ·  ✓ Pause or cancel anytime  ·  ✓ Never run out

ComparisonKidney VitalityTypical high-street multivitamin
Added potassiumNoneOften included
Added phosphateNoneOften included (E338–E452)
Vitamin A (retinol)No megadoseOften high-dose retinol
Kidney-focused formulationYesNo — general population
Consultant Nephrologist involvementYes (GMC 7216325)No
UK GMP manufacturedYes (BRCGS, NSF GMP)Varies

Food supplement. Not a medicine and not a treatment for kidney disease. Speak with your GP, pharmacist or renal team before starting any new supplement, especially in advanced CKD, on dialysis, post-transplant, pregnant or breastfeeding.

Clinical reviewer

Professor Mohammed Mahdi Althaf

Consultant Nephrologist

Acute Physician

GMC 7216325

View Full Biography

Professor Mohammed Mahdi Althaf is a UK Consultant Nephrologist and Acute Physician with a special interest in chronic kidney disease, AKI prevention and renal nutrition. He combines hospital practice with patient education and clinical guidance review.

View professional profile →
View Credentials
  • MD
  • MSc
  • PgDip (Clin Ed)
  • FRCP
  • FHEA
  • FASN

About this article

Written for UK patients and based on:

  • NICE guidance
  • NHS resources
  • British Dietetic Association guidance
  • Kidney Care UK resources
View methodology

Each article is researched against current UK clinical guidance (NICE NG203, NG118, NG136), NHS patient resources, KDIGO and KDOQI international guidelines, and the British Dietetic Association Renal Nutrition Group. Drafts are written by the Kidney Vitality editorial team and reviewed by a UK Consultant Nephrologist before publication. Content is reviewed on a rolling basis and updated when guidance changes.

Editorial standards

  • Clinically reviewed
  • NHS-aligned
  • NICE-aligned
  • Evidence-based
  • Reviewed before publication
View full editorial process

Every article is researched and written by the Kidney Vitality editorial team using current UK clinical guidance (NICE NG203, NG118, NG136), NHS patient resources, KDIGO/KDOQI international guidelines, and British Dietetic Association renal nutrition guidance. Drafts are reviewed for clinical accuracy by Professor Mohammed Mahdi Althaf, MD, MSc, PgDip (Clin Ed), FRCP, FHEA, FASN (Consultant Nephrologist & Acute Physician, GMC 7216325) before publication. Content is updated when UK guidance changes.

References (4)View Sources
  1. NICE NG203: Chronic kidney disease — assessment and management
  2. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD
  3. KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update
  4. British Dietetic Association — Renal Nutrition Group

Medical disclaimer

This content is educational only and does not replace personalised medical advice.

Read full disclaimer

This page is general information, not personal medical advice. If you have chronic kidney disease, are on dialysis, have had a kidney transplant, are pregnant or breastfeeding, or take prescription medication, please confirm any supplement with your GP, pharmacist or renal team before starting.

← Back to all guides